T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$1.3B |
| 2 |
American Airlines Group
AAL
|
+$853M |
| 3 |
Intuitive Surgical
ISRG
|
+$816M |
| 4 |
Morgan Stanley
MS
|
+$681M |
| 5 |
Wynn Resorts
WYNN
|
+$622M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$1.4B |
| 2 |
eBay
EBAY
|
+$763M |
| 3 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$760M |
| 4 |
Broadcom
AVGO
|
+$757M |
| 5 |
US Bancorp
USB
|
+$686M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.64% |
| 2 | Consumer Discretionary | 13.46% |
| 3 | Financials | 12.79% |
| 4 | Industrials | 12.13% |
| 5 | Technology | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ESGR
751
DELISTED
Enstar Group
ESGR
| $69.6M | 0.02% |
461,666
-5,100
| -1% | -$702K |
|
752
PPG Industries
PPG
$25.5B
| $69.3M | 0.02% |
659,502
-159,532
| -19% | -$15.8M |
|
753
Healthcare Services Group
HCSG
$1.45B
| $69.1M | 0.01% |
2,348,527
+31,913
| +1% | +$942K |
|
754
Black Hills Corp
BKH
$5.64B
| $69.1M | 0.01% |
1,125,564
-580
| -0.1% | -$33.7K |
|
755
Kimberly-Clark
KMB
$36.8B
| $69M | 0.01% |
646,676
+5,622
| +0.9% | +$597K |
|
|
EIGI
756
DELISTED
Endurance International Group Holdings, Inc.
EIGI
| $68.6M | 0.01% |
4,486,100
+1,655,100
| +58% | +$21.9M |
|
757
Boston Scientific
BSX
$74.9B
| $68.3M | 0.01% |
5,346,933
-117,520
| -2% | -$1.53M |
|
758
Dominion Energy
D
$60.3B
| $67.6M | 0.01% |
945,455
+19,011
| +2% | +$1.33M |
|
759
Baxter International
BAX
$14B
| $67.5M | 0.01% |
1,717,881
+25,019
| +1% | +$1M |
|
|
ATRI
760
DELISTED
Atrion Corp
ATRI
| $67.2M | 0.01% |
206,195
+4,645
| +2% | +$1.42M |
|
761
Fabrinet
FN
$20.3B
| $67.2M | 0.01% |
3,262,100
-70,910
| -2% | -$1.44M |
|
|
LVNTA
762
DELISTED
Liberty Interactive Corporation Series A Liberty Ventures
LVNTA
| $67M | 0.01% |
1,846,714
-536,833
| -23% | -$16.9M |
|
763
Royal Gold
RGLD
$19.1B
| $66.8M | 0.01% |
877,942
-120,722
| -12% | -$7.98M |
|
764
Southern Company
SO
$107B
| $66.5M | 0.01% |
1,465,002
+28,400
| +2% | +$1.26M |
|
765
Prothena Corp
PRTA
$466M
| $66.2M | 0.01% |
2,935,996
+680,600
| +30% | +$17M |
|
766
Moog Inc Class A
MOG.A
$13.5B
| $66.2M | 0.01% |
907,647
+2,800
| +0.3% | +$192K |
|
767
The Greenbrier Companies
GBX
$1.42B
| $66.1M | 0.01% |
1,147,900
+1,100
| +0.1% | +$57.4K |
|
768
Kforce
KFRC
$1.08B
| $66.1M | 0.01% |
3,051,196
-675,890
| -18% | -$14.7M |
|
769
Selective Insurance
SIGI
$5.59B
| $66M | 0.01% |
2,671,770
-11,450
| -0.4% | -$270K |
|
770
CSX Corp
CSX
$92.9B
| $65.8M | 0.01% |
6,408,951
+6,597
| +0.1% | +$64.2K |
|
|
VALE.P
771
DELISTED
Vale S A
VALE.P
| $65.6M | 0.01% |
5,515,958
+438,803
| +9% | +$5.34M |
|
772
Exelixis
EXEL
$12.5B
| $65.4M | 0.01% |
19,295,340
-61,070
| -0.3% | -$211K |
|
|
CWEI
773
DELISTED
Clayton Williams Energy, Inc.
CWEI
| $65.1M | 0.01% |
473,884
-262,040
| -36% | -$33.6M |
|
|
ELRC
774
DELISTED
ELECTRO RENT CORP
ELRC
| $65.1M | 0.01% |
3,889,080
+3,700
| +0.1% | +$59.3K |
|
775
TriMas Corp
TRS
$1.39B
| $64.7M | 0.01% |
2,129,584
-29,581
| -1% | -$824K |
|
Similar funds
T. Rowe Price Associates's Q2 2014 Portfolio in Review
As of Q2 2014, T. Rowe Price Associates held 2,596 positions worth $463B, up 3.9% from $445B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
T. Rowe Price Associates's Q2 2014 filing shows 97 new, 1,091 increased, 793 reduced and 67 closed positions. Its largest new stake was Teva Pharmaceuticals: 4,638,481 shares worth $243M. The largest sale was Procter & Gamble, an estimated $1.4B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2014 buy was Teva Pharmaceuticals: 4,638,481 shares worth $243M.
- T. Rowe Price Associates added most to Allergan Inc in Q2 2014, an estimated $1.3B increase.
- T. Rowe Price Associates's biggest Q2 2014 reduction was Procter & Gamble, cutting an estimated $1.4B.
- T. Rowe Price Associates fully exited Santander in Q2 2014, selling an estimated $134M.
- T. Rowe Price Associates's ten largest holdings make up 12% of its $463B portfolio in Q2 2014.
- T. Rowe Price Associates opened 97 new positions and closed 67 in Q2 2014.
- T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $463B.
Based on T. Rowe Price Associates's 13F filing for Q2 2014, filed 14 Aug 2014.